Sagimet Biosciences IncNASDAQ:SGMT
- LAST PRICE4.0600
- TODAY'S CHANGE (%)0.1400 (3.5714%)
- Bid / Lots4.0700/ 13
- Ask / Lots4.8200/ 1
- Open / Previous Close4.0000 / 3.9200
- Day Range
- 52 Week Range
- Volume325,272
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SGMT |
|---|---|---|
| 09:32 ET | 1886 | 4 |
| 09:34 ET | 2600 | 3.975 |
| 09:36 ET | 300 | 3.97 |
| 09:38 ET | 4429 | 3.94 |
| 09:39 ET | 110 | 3.94 |
| 09:41 ET | 1400 | 3.96 |
| 09:43 ET | 400 | 4 |
| 09:45 ET | 3106 | 3.9606 |
| 09:48 ET | 100 | 3.96 |
| 09:50 ET | 1100 | 3.94 |
| 09:52 ET | 1230 | 4.01 |
| 09:56 ET | 1200 | 3.975 |
| 09:57 ET | 3499 | 3.9797 |
| 10:01 ET | 600 | 3.975 |
| 10:06 ET | 100 | 3.975 |
| 10:08 ET | 300 | 3.97 |
| 10:10 ET | 200 | 3.96 |
| 10:12 ET | 720 | 3.94 |
| 10:15 ET | 200 | 3.96 |
| 10:17 ET | 1096 | 3.95 |
| 10:19 ET | 2432 | 3.95 |
| 10:21 ET | 200 | 3.97 |
| 10:28 ET | 238 | 3.95 |
| 10:30 ET | 924 | 3.94 |
| 10:32 ET | 600 | 3.94 |
| 10:33 ET | 700 | 3.954 |
| 10:35 ET | 415 | 3.96 |
| 10:42 ET | 200 | 3.94 |
| 10:44 ET | 1500 | 3.94 |
| 10:46 ET | 100 | 3.93 |
| 10:48 ET | 5749 | 3.93 |
| 10:50 ET | 500 | 3.92 |
| 10:51 ET | 34129 | 3.895 |
| 10:53 ET | 5800 | 3.9056 |
| 10:55 ET | 4823 | 3.92 |
| 10:57 ET | 800 | 3.9167 |
| 11:00 ET | 535 | 3.91 |
| 11:02 ET | 900 | 3.92 |
| 11:04 ET | 1358 | 3.9001 |
| 11:06 ET | 924 | 3.9127 |
| 11:09 ET | 100 | 3.9 |
| 11:11 ET | 100 | 3.9 |
| 11:13 ET | 910 | 3.9 |
| 11:15 ET | 200 | 3.91 |
| 11:18 ET | 1854 | 3.91 |
| 11:20 ET | 400 | 3.91 |
| 11:22 ET | 950 | 3.9006 |
| 11:24 ET | 100 | 3.9 |
| 11:26 ET | 100 | 3.9 |
| 11:27 ET | 916 | 3.905 |
| 11:29 ET | 700 | 3.92 |
| 11:33 ET | 2491 | 3.919 |
| 11:36 ET | 2950 | 3.91 |
| 11:38 ET | 2270 | 3.935 |
| 11:42 ET | 100 | 3.935 |
| 11:47 ET | 300 | 3.95 |
| 11:56 ET | 3226 | 3.97 |
| 11:58 ET | 1096 | 4 |
| 12:00 ET | 3336 | 4.05 |
| 12:02 ET | 1263 | 4.06 |
| 12:14 ET | 9034 | 4.07 |
| 12:20 ET | 1049 | 4.03 |
| 12:27 ET | 300 | 4.055 |
| 12:32 ET | 150 | 4.0519 |
| 12:34 ET | 612 | 4.06 |
| 12:39 ET | 1436 | 4.06 |
| 12:45 ET | 100 | 4.05 |
| 12:50 ET | 300 | 4.05 |
| 12:54 ET | 100 | 4.06 |
| 12:56 ET | 4000 | 4.0502 |
| 12:57 ET | 702 | 4.0535 |
| 12:59 ET | 200 | 4.055 |
| 01:01 ET | 200 | 4.07 |
| 01:03 ET | 850 | 4.06 |
| 01:10 ET | 300 | 4.06 |
| 01:12 ET | 100 | 4.05 |
| 01:15 ET | 602 | 4.07 |
| 01:21 ET | 660 | 4.1099 |
| 01:24 ET | 800 | 4.12 |
| 01:32 ET | 1700 | 4.11 |
| 01:33 ET | 350 | 4.1 |
| 01:37 ET | 600 | 4.1007 |
| 01:44 ET | 700 | 4.09 |
| 01:46 ET | 420 | 4.09 |
| 01:51 ET | 2735 | 4.1 |
| 01:53 ET | 18728 | 4.115 |
| 01:55 ET | 20199 | 4.12 |
| 01:57 ET | 827 | 4.1 |
| 02:00 ET | 6036 | 4.12 |
| 02:02 ET | 300 | 4.12 |
| 02:04 ET | 100 | 4.13 |
| 02:06 ET | 430 | 4.14 |
| 02:08 ET | 17496 | 4.125 |
| 02:09 ET | 5143 | 4.14 |
| 02:11 ET | 11372 | 4.12 |
| 02:13 ET | 1014 | 4.12 |
| 02:15 ET | 1254 | 4.11 |
| 02:18 ET | 1300 | 4.11 |
| 02:20 ET | 2000 | 4.1093 |
| 02:22 ET | 1600 | 4.1 |
| 02:27 ET | 300 | 4.09 |
| 02:40 ET | 100 | 4.1 |
| 02:42 ET | 400 | 4.1 |
| 02:51 ET | 1000 | 4.0999 |
| 02:56 ET | 1447 | 4.08 |
| 02:58 ET | 1600 | 4.07 |
| 03:07 ET | 500 | 4.09 |
| 03:14 ET | 400 | 4.08 |
| 03:16 ET | 200 | 4.0878 |
| 03:20 ET | 100 | 4.07 |
| 03:25 ET | 3169 | 4.0801 |
| 03:32 ET | 325 | 4.1 |
| 03:34 ET | 100 | 4.09 |
| 03:45 ET | 3308 | 4.06 |
| 03:48 ET | 519 | 4.06 |
| 03:50 ET | 2426 | 4.07 |
| 03:52 ET | 287 | 4.06 |
| 03:54 ET | 1029 | 4.07 |
| 03:56 ET | 10083 | 4.08 |
| 03:57 ET | 1738 | 4.08 |
| 03:59 ET | 7415 | 4.06 |
Apr 22, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sagimet Biosciences Inc | 129.6M | -3.1x | --- |
Omega Therapeutics Inc | 125.2M | -1.3x | --- |
Vistagen Therapeutics Inc | 128.4M | -1.3x | --- |
Leap Therapeutics Inc | 124.3M | -0.6x | --- |
Bioatla Inc | 122.2M | -1.0x | --- |
Adicet Bio Inc | 138.0M | -0.5x | --- |
Company Information
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. The Company's lead drug candidate, denifanstat, is an oral, once-daily pill and the selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). In addition to MASH, the Company is evaluating denifanstat in acne and in select forms of cancer, disease areas in which dysregulation of fatty acid metabolism also plays a key role. Denifanstat is being tested in a Phase III clinical trial for moderate to severe acne vulgaris, and a Phase III trial for recurrent glioblastoma multiforme (GBM) in combination with bevacizumab.
Contact Information
- Headquarters
- 155 BOVET RD., SUITE 303SAN MATEO, CA, United States 94402
- Phone
- 650-561-8600
- Fax
- 302-730-1370
Executives
- Executive Chairman of the Board
- George Kemble
- President, Chief Executive Officer, Director
- David Happel
- Interim Principal Financial Officer, Interim Principal Accounting Officer
- Joseph Oriti
- Chief Operating Officer
- Anthony Rimac
- Chief Compliance Officer, General Counsel
- Elizabeth Rozek
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $129.6M |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.31 |
Book Value | $3.98 |
P/E Ratio | -3.1x |
Price/Sales (TTM) | 64.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,537.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
